Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026)
Grown Rogue International (GRUSF) posted quarterly Cash from Operations of 2534524.0 for Q1 2026, up 352.3% year-over-year from 560367.34 in Q1 2025, and up 100.0% quarter-over-quarter from 230723430205.0 in Q4 2025.
Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026) Analysis & Trends
Grown Rogue International's Cash from Operations history runs 14 years deep, the most recent figure standing at 2534524.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 352.3% year-over-year to 2534524.0; the TTM figure through Mar 2026 stood at 230721396777.04 (down 7223113.21% YoY), while the FY2025 annual figure was 3569795.0, up 36.51% from the prior year.
- Cash from Operations for Q1 2026 stood at 2534524.0, up from 230723430205.0 in the prior quarter.
- The five-year high for Cash from Operations was 3586881.17 in Q4 2023, with the low at 230723430205.0 in Q4 2025.
- The 5-year median for Cash from Operations is 1224938.11 (2024), against an average of 17746740932.31.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations surged 967.93% in 2023, then slumped 15247565.85% in 2025.
- Grown Rogue International's Cash from Operations stood at 60103.09 in 2022, then surged by 5867.88% to 3586881.17 in 2023, then sank by 57.81% to 1513191.98 in 2024, then sank by 15247565.85% to 230723430205.0 in 2025, then soared by 100.0% to 2534524.0 in 2026.
- Business Quant data shows GRUSF's Cash from Operations at 2534524.0 in Q1 2026, 230723430205.0 in Q4 2025, and 503483.96 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | -230.72 Bn |
| Dec 31, 2025 | -230.72 Bn |
| Jun 30, 2025 | 503,483.96 |
| Jun 30, 2025 | 503,483.96 |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 995,729.65 |
| Mar 31, 2024 | 995,729.65 |
| Oct 31, 2023 | 3.59 Mn |
| Oct 31, 2023 | 3.59 Mn |